This is a targeted therapeutic strategy focused on preventing the reduction in the number or responsiveness of hormone receptors, which typically occurs following prolonged exposure to high concentrations of an agonist hormone. In practice, this is vital when administering exogenous sex hormones or growth factors to ensure sustained cellular responsiveness and avoid the need for escalating doses to achieve the same clinical effect. It preserves the body’s ability to respond effectively.
Origin
The term is rooted in cellular endocrinology, where “downregulation” describes the adaptive decrease in receptor numbers following chronic stimulation. “Avoidance” implies employing specific dosing or administration schedules to circumvent this negative feedback mechanism at the cellular level. This strategy is essential for the long-term sustainability of hormone modulation therapies.
Mechanism
Avoidance strategies often involve introducing periods of lower hormonal exposure or cycling the administration frequency to allow receptor populations to replenish their surface expression. For instance, administering testosterone in a pulsatile manner rather than a constant steady state can prevent the androgen receptor from internalizing excessively. This modulation ensures that the cell remains highly sensitive to the available circulating hormone concentrations.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.